Pioneering a new approach to biological discovery
IPI blends academic exploration with industrial scalability
to tap the full potential of recombinant antibodies.
Our proteins power discovery
IPI is a nonprofit research hybrid that invests in high-throughput technologies and deep protein expertise to bring biological research up to speed.
Academic expertise
Our Harvard-based scientists collaboratively take on complex projects in the areas most in need of transformative antibodies and other proteins.
Industrial platform
We achieve unprecedented scale with a platform and technologies based on high-quality protein and antibody design, expression and production.
IPI in brief

Meeting research needs
IPI scientists deploy cutting-edge technologies and techniques, such as antibody engineering and a yeast display library, to tap the full potential of synthetic recombinant antibodies.

Best of both worlds
IPI combines deep academic expertise with industrial scalability, investing in high-throughput technologies and automation to bring biological research up to speed.

Unique business model
IPI is a nonprofit institute with assured funding and the high-caliber expertise to support exploratory protein research.

Cross-disciplinary connections
IPI is poised to elevate life science communities, collaborating with biologists across specialties and training young scientists.
Building collaborations
IPI believes the best science crosses fields. We draw together multiple disciplines to build antigen and antibody tools for basic biological research and therapeutic discovery.
Uncovering the secrets of mechanotransduction, one integrin receptor at a time
For the body to function, cells must decide. Embryonic cells elect to reproduce and shape into budding limbs. Immune cells choose to leave the bloodstream en...
Engineering Protein A to Z for VH3 antibody purification
Antibody purification is often taken for granted. It’s an essential step in isolating desirable antibodies for research and drug development and a standard part of antibody...
Inside the IPI pipeline
Of the tools underpinning biomedical research, antibodies are among the most impactful. Their ability to recognize and attach to biomolecules has powered fundamental discoveries, diagnostic methods...
Bioscience leader Ken Fasman to steer IPI as new president and CEO
The walls of Ken Fasman’s ninth-floor office are still bare. But the new president and CEO at the Institute for Protein Innovation (IPI) has plans that...